What pregnancy, fertility, and contraception questions should be discussed before a compounded GLP-1?

Stop GLP-1s at least 2 months before pregnancy. Discuss backup contraception as GLP-1s can reduce oral pill efficacy. Fertility effects are unknown.

GLP-1 Medications and Pregnancy Risk

GLP-1 receptor agonists like semaglutide and tirzepatide are not recommended for use during pregnancy. The FDA labels for brand-name versions carry warnings based on animal reproduction studies. These studies showed potential risks, including fetal malformations, embryonic-fetal mortality, and reduced fetal growth.

Due to these findings, there is a potential risk of fetal harm in humans. There is currently not enough data from human pregnancies to determine a definitive drug-associated risk. For this reason, the medication should be discontinued as soon as pregnancy is detected.

Physicians recommend that individuals stop taking GLP-1 medications at least two months before a planned pregnancy. This "washout period" allows the drug to fully clear from your system, minimizing any potential risk to a developing fetus. This recommendation is based on the half-life of the medications.

Interaction with Oral Contraceptives

GLP-1 medications work in part by delaying gastric emptying, which means food and other substances stay in your stomach longer. This action can affect the absorption of oral medications, including oral contraceptive pills, potentially reducing their effectiveness.

This interaction is most significant when you first start the medication or after a dose increase. During these periods, the change in gastric emptying speed is most pronounced. The FDA label for tirzepatide specifically advises patients using oral contraceptives to switch to a non-oral method or add a barrier method for 4 weeks after starting and 4 weeks after each dose increase.

For semaglutide, clinical trials did not show a clinically relevant impact on the absorption of oral contraceptives. However, due to the mechanism of action, it is a critical point to discuss with your prescribing physician. They may advise using a backup method of birth control as a precaution.

Before starting any GLP-1 medication under physician-supervision, you must inform your doctor about all medications you take, especially oral contraceptives, to create a safe and effective treatment plan.

Fertility and Planning for Pregnancy

The direct effects of GLP-1 medications on human fertility are not well-studied. Animal studies on semaglutide and tirzepatide have not shown direct negative impacts on fertility. However, the absence of human data means caution is the standard approach.

For individuals with conditions like Polycystic Ovary Syndrome (PCOS), weight loss achieved with a GLP-1 can sometimes improve metabolic health and restore regular ovulation, potentially increasing fertility. This makes pre-conception planning and reliable contraception even more important while on the medication.

If you are planning to become pregnant, the primary guidance is to discontinue the GLP-1 at least two months before you start trying to conceive. This allows for a drug-free system during the critical early stages of fetal development. You can find more information in our GOAL.MD Answer library at /answers.

Considerations for Men

For men on GLP-1 medications who are planning to start a family, the available data is also limited. According to the FDA labels for brand-name semaglutide and tirzepatide, animal studies in males did not show any adverse effects on mating performance or fertility.

Despite the reassuring animal data, the effects on human male fertility and sperm parameters have not been specifically studied. Men planning for fatherhood should discuss this topic with their physician as part of the overall risk and benefit assessment before starting treatment.

The conversation should be part of a comprehensive family planning discussion with your partner and healthcare providers to ensure all factors are considered.

Checklist for Your Physician Discussion

To ensure a safe and effective treatment plan, prepare to discuss the following points with your physician before starting a compounded GLP-1 medication:

1. **Pregnancy Plans:** Inform your doctor of any plans to become pregnant now or in the future. Ask for a clear timeline for when to stop the medication before trying to conceive.

2. **Contraception Method:** Detail your current form of birth control. If it is an oral pill, ask directly if its effectiveness could be compromised and if a backup or alternative method is needed.

3. **Unexpected Pregnancy:** Discuss the protocol if you become pregnant unexpectedly while taking the medication. The standard recommendation is to stop the medication immediately and contact your physician.

4. **Medication Adjustments:** Ask if you need to take extra contraceptive precautions when you first start the GLP-1 or any time your dose is increased. This is a period of heightened risk for reduced oral medication absorption.

Bottom Line

GLP-1 medications are contraindicated during pregnancy due to potential fetal harm shown in animal studies. It is crucial to stop these drugs at least two months before attempting conception. These medications, which are prepared by licensed U.S. pharmacies for your physician-supervised program, are not FDA-approved.

Furthermore, GLP-1s can interfere with the absorption of oral contraceptives, potentially reducing their efficacy. This requires a careful discussion with your physician about backup or alternative methods of birth control, especially when initiating or escalating your dose.

A thorough conversation with your healthcare provider about your fertility goals, pregnancy plans, and contraceptive methods is a mandatory step before beginning treatment with any compounded GLP-1 medication.

This article is for informational purposes only and does not constitute medical advice.

Drafted by the GOAL.MD Authority Engine and approved editorially by GOAL.MD staff. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.